Zhejiang Hisoar Pharmaceutical Co., Ltd. elected Tao Hong as non-independent director; and Yu Yongping, Qian Jianmin and Liang Chao as independent directors at the Extraordinary General Meeting held on November 30, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.31 CNY | -0.47% | -2.02% | -12.24% |
04-28 | Zhejiang Hisoar Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-18 | Hisoar Pharma's Unit Passes German Health Regulator's Inspection | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.24% | 1.39B | |
+29.20% | 682B | |
+29.94% | 586B | |
-3.36% | 364B | |
+17.99% | 327B | |
+3.77% | 285B | |
+16.02% | 240B | |
+10.31% | 209B | |
-8.55% | 203B | |
+7.57% | 165B |
- Stock Market
- Equities
- 002099 Stock
- News Zhejiang Hisoar Pharmaceutical Co., Ltd.
- Zhejiang Hisoar Pharmaceutical Co., Ltd. Elects Tao Hong as Non-Independent Director; and Yu Yongping, Qian Jianmin and Liang Chao as Independent Directors